裸金属支架相关论文
目的探索普通球囊血管成形术（BA）、裸金属支架（BMS）、药物洗脱球囊（DEB）和药物洗脱支架（DES）4种方法治疗膝下动脉闭塞性病变疗效的差异。方......
目的分析比较裸金属支架(BMS)、药物涂层球囊(DCB)及药物洗脱支架(DES)在冠心病高出血风险(HBR)患者中应用的有效性和安全性。方法......
冠脉内支架置入术目前在临床上广泛应用 ,但内膜增生造成 10 %～ 6 0 % [1] 病人支架内再狭窄 (In StentRestenosis,ISR)。ISR限制了......
Erdim R,Helvacioglu F,Gormez S,et al.Two-year follow-up of sirolimus-eluting stents versus paclitaxel-eluting stents in ......
患者为60岁男性,主因反复胸痛1年,加重3个月入院.既往有高血压病史15年,糖尿病史1个月.入院体格检查:血压130/80 mm Hg(1 mm Hg=0.......
在科学与实践之间架起一座桥梁是美国心脏病学会(ACC)一贯的宗旨.每年的ACC年会就是保证医务工作者们更清楚地了解科学实践的意义,......
Despite the proven superiority of sirolimus-eluting stents(SESs) compared with bare stents in the first year after impla......
Background- The use of sirolimus- eluting coronary stents has been associated with a nearly complete elimination of rest......
Bare-metal stenting with abciximab pretreatment is currently considered a reasonable reperfusion strategy for acute ST-s......
OBJECTIVES: The purpose of this study was to investigate the medium-term(two year) outcome of the unrestricted utilizati......
Aims: Endothetial dysfunction has been related both to progression of atheros clerotic disease and to future cardiovascu......
OBJECTIVES: The purpose of this study was to examine the two-year clinical ou tcomes in patients enrolled in the Sirolim......
Objectives: This study sought to evaluate the effectiveness and safety of the sirolimus-eluting stent in the treatment o......
duce the frequency of neointimal hyperplasia and restenosis compared with bare metal stents. However, the clinical impli......
Randomized trials have shown that implantation of sirolimus-eluting stents(SESs) and paclitaxel-eluting stents(PESs) red......
Context: Although vascular brachytherapy is the only approved therapy for restenosis following bare-metal stent implanta......
Context: Compared with bare metal stents, sirolimus-elut-ing and paclitaxel-eluting stents have been shown to markedly i......
RESEARCH(Rapamycin-Eluting Stent Evaluated at RotterdamCardiology Hospital)注册最新公布的中期(2年)研究结果表明,西罗莫司......
韩国学者Kim等进行了一项调查阿昔单抗涂层支架治疗急性心肌梗死(AMI)患者临床结果的前瞻性随机试验。目前已经证实阿昔单抗涂层支......
Context: Restenosis within bare-metal stents is often treated with repeat percutaneous coronary intervention, although s......
Thienopyridines and aspirin are beneficial in patients undergoing bare-metal stent implantation, and aspirin and clopido......
目的:评价在分支处病变应用“crush”支架技术置入雷帕霉素或紫杉醇药物洗脱支架后的远期疗效。背景:当前认为,对分支处病变处理最......
再次冠脉内介入治疗是裸金属支架内再狭窄的常用治疗方法,但是这样处理后的再次再狭窄率依然很高,研究表明再次冠脉内介入治疗的同......
Background: Restenosis after percutaneous coronary intervention(PCI) has been thought to present in a stable manner as e......
自从冠状动脉血管成形术出现以来,靶病变再狭窄的发生限制了该技术的应用。再狭窄过程包括急性血管回缩、慢性重塑及内膜增生等机......
Background:Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk o......
Prospective follow-up at 2 years was obtained for 98.7%of the pooled 1,510 patients enrolled in SIRIUS, E-SIRIUS and C-S......
在阿根廷进行的前瞻性随机对照非盲研究(ORARⅡ)对100例冠脉裸金属支架病人随机分组,治疗组给予雷帕霉素(术前6mg,术后3mg/d×14d)......
随着介入技术的发展及金属支架的广泛应用,裸金属支架内再狭窄成为当今介入医师最关注及迫切需要解决的问题。血管内放射治疗(VBT)......
Objectives: This study sought to compare aggregate medical care costs for patients undergoing percutaneous coronary inte......
2006年10月22-27日在美国华盛顿召开的经导管心血管治疗学(TCT)大会上,Leon和Stone医生报告了Cypher支架和TAXUS支架9个随机临床试......
不久前在西班牙巴塞罗那召开的世界心脏病学大会(WCC)和欧洲心脏病学年会(ESC)上,Camenzind 医师报告了一项关于第一代药物洗脱支......
背景:已有研究表明,与裸金属支架相比,紫杉醇洗脱支架(PES)可降低再狭窄发生率和再次血运重建的需要。然而,紫杉醇对血管功能的远......
药物洗脱冠状动脉支架(DES)已成为冠心病介入治疗的里程碑.但是,尽管第一代DES比裸金属支架(BMS)明显降低了再狭窄率,美国心脏学会......
与裸金属支架相比,西罗莫司洗脱支架(SES)和紫杉醇洗脱支架(PES)可显著减少再次介入的需要。在经过选择的患者及病变组中,使用这些......
目的:利用RESEARCH(鹿特丹心脏病医院雷帕霉素洗脱支架评估)注册研究中的非选择性患者,比较以西罗莫司洗脱支架(SES)与裸金属支架(......
本文讨论2例非闭塞性亚急性(或晚期)支架血栓形成患者,其中1例在西罗莫司洗脱支架置入后12d时被准确诊断(借助血管内超声检查),另1......
RRISC(利用Cypher西罗莫司洗脱支架减少隐静脉桥再狭窄)随机试验比较了隐静脉桥(SVG)使用西罗莫司洗脱支架(SES)与裸金属支架(BMS)......
目的:虽然药物洗脱支架被认为在介入心脏病学中占有重要地位,但其长期潜在的负面后果(包括死亡在内)已引起了人们的关注。本研究旨......
背景:药物洗脱支架(DES)应用的长期安全性和有效性近来受到质疑。方法和结果:在2002年7月至2005年6月间,10629例应用DES(n=3064)或......
